BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 27796131)

  • 1. Maternal Highly Active Antiretroviral Therapy Reduces Vertical Cytomegalovirus Transmission But Does Not Reduce Breast Milk Cytomegalovirus Levels.
    Slyker JA; Richardson B; Chung MH; Atkinson C; Ásbjörnsdóttir KH; Lehman DA; Boeckh M; Emery V; Kiarie J; John-Stewart G
    AIDS Res Hum Retroviruses; 2017 Apr; 33(4):332-338. PubMed ID: 27796131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial.
    Chung MH; Kiarie JN; Richardson BA; Lehman DA; Overbaugh J; Kinuthia J; Njiri F; John-Stewart GC
    Antivir Ther; 2008; 13(6):799-807. PubMed ID: 18839781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 persists in breast milk cells despite antiretroviral treatment to prevent mother-to-child transmission.
    Lehman DA; Chung MH; John-Stewart GC; Richardson BA; Kiarie J; Kinuthia J; Overbaugh J
    AIDS; 2008 Jul; 22(12):1475-85. PubMed ID: 18614871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compartmentalized cytomegalovirus replication and transmission in the setting of maternal HIV-1 infection.
    Slyker J; Farquhar C; Atkinson C; Ásbjörnsdóttir K; Roxby A; Drake A; Kiarie J; Wald A; Boeckh M; Richardson B; Odem-Davis K; John-Stewart G; Emery V
    Clin Infect Dis; 2014 Feb; 58(4):564-72. PubMed ID: 24192386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower risk of resistance after short-course HAART compared with zidovudine/single-dose nevirapine used for prevention of HIV-1 mother-to-child transmission.
    Lehman DA; Chung MH; Mabuka JM; John-Stewart GC; Kiarie J; Kinuthia J; Overbaugh J
    J Acquir Immune Defic Syndr; 2009 Aug; 51(5):522-9. PubMed ID: 19502990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of prenatal highly active antiretroviral therapy on the transmission of congenital and perinatal/early postnatal cytomegalovirus among HIV-infected and HIV-exposed infants.
    Frederick T; Homans J; Spencer L; Kramer F; Stek A; Operskalski E; Kovacs A
    Clin Infect Dis; 2012 Sep; 55(6):877-84. PubMed ID: 22675157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal reduction of HIV type 1 viral load in breast milk by single-dose nevirapine during prevention of MTCT.
    Rossenkhan R; Ndung'u T; Sebunya TK; Hagan JE; Shapiro R; Novitsky V; Moyo SM; Thior I; Lockman S; Mitchell R; Kim S; Musonda R; van Widenfelt E; Makhema J; Essex M
    AIDS Res Hum Retroviruses; 2009 Dec; 25(12):1261-4. PubMed ID: 20001515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus (CMV) DNA load in breast milk of human immunodeficiency virus-positive women and infant CMV infection acquisition are not reduced with long-term antiretroviral therapy.
    Giuliano M; Pirillo MF; Liotta G; Andreotti M; Floridia M; Ciccacci F; Jere H; Sagno JB; Amici R; Mancinelli S; Marazzi MC; Vella S; Palombi L
    Clin Microbiol Infect; 2017 Jul; 23(7):491-492. PubMed ID: 28193527
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly active antiretroviral therapy started during pregnancy or postpartum suppresses HIV-1 RNA, but not DNA, in breast milk.
    Shapiro RL; Ndung'u T; Lockman S; Smeaton LM; Thior I; Wester C; Stevens L; Sebetso G; Gaseitsiwe S; Peter T; Essex M
    J Infect Dis; 2005 Sep; 192(5):713-9. PubMed ID: 16088820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Birth prevalence of congenital cytomegalovirus among infants of HIV-infected women on prenatal antiretroviral prophylaxis in South Africa.
    Manicklal S; van Niekerk AM; Kroon SM; Hutto C; Novak Z; Pati SK; Chowdhury N; Hsiao NY; Boppana SB
    Clin Infect Dis; 2014 May; 58(10):1467-72. PubMed ID: 24567248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal valacyclovir and infant cytomegalovirus acquisition: a randomized controlled trial among HIV-infected women.
    Roxby AC; Atkinson C; Asbjörnsdóttir K; Farquhar C; Kiarie JN; Drake AL; Wald A; Boeckh M; Richardson B; Emery V; John-Stewart G; Slyker JA
    PLoS One; 2014; 9(2):e87855. PubMed ID: 24504006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valacyclovir suppressive therapy reduces plasma and breast milk HIV-1 RNA levels during pregnancy and postpartum: a randomized trial.
    Drake AL; Roxby AC; Ongecha-Owuor F; Kiarie J; John-Stewart G; Wald A; Richardson BA; Hitti J; Overbaugh J; Emery S; Farquhar C
    J Infect Dis; 2012 Feb; 205(3):366-75. PubMed ID: 22147786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Freeze-Thawing Method in Reducing Viral Load of Cytomegalovirus in Breast Milk of Mothers of Preterm Infants.
    Hosseini M; Esmaili HA; Abdoli Oskouei S; Gojazadeh M; MokariYamchi Z; Layegh V; Emami L; MokariYamchi A
    Breastfeed Med; 2016 Dec; 11():557-560. PubMed ID: 27754707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CMV infection in a cohort of HIV-exposed infants born to mothers receiving antiretroviral therapy during pregnancy and breastfeeding.
    Pirillo MF; Liotta G; Andreotti M; Jere H; Sagno JB; Scarcella P; Mancinelli S; Buonomo E; Amici R; Marazzi MC; Vella S; Palombi L; Giuliano M
    Med Microbiol Immunol; 2017 Feb; 206(1):23-29. PubMed ID: 27629556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women.
    Ngemu EK; Khayeka-Wandabwa C; Kweka EJ; Choge JK; Anino E; Oyoo-Okoth E
    BMC Res Notes; 2014 Jan; 7():52. PubMed ID: 24447387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of maternal highly active antiretroviral therapy and short-course combination antiretrovirals for prevention of mother-to-child transmission on early infant infection rates at the Mulago national referral hospital in Kampala, Uganda, January 2007 to May 2009.
    Namukwaya Z; Mudiope P; Kekitiinwa A; Musoke P; Matovu J; Kayma S; Salmond W; Bitarakwate E; Mubiru M; Maganda A; Galla M; Byamugisha J; Fowler MG
    J Acquir Immune Defic Syndr; 2011 Jan; 56(1):69-75. PubMed ID: 21099692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nevirapine, sodium concentration and HIV-1 RNA in breast milk and plasma among HIV-infected women receiving short-course antiretroviral prophylaxis.
    Salado-Rasmussen K; Theilgaard ZP; Chiduo MG; Bygbjerg IC; Gerstoft J; Lüneborg-Nielsen M; Lemnge M; Katzenstein TL
    PLoS One; 2015; 10(3):e0121111. PubMed ID: 25812161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine.
    Chung MH; Kiarie JN; Richardson BA; Lehman DA; Overbaugh J; John-Stewart GC
    AIDS; 2005 Sep; 19(13):1415-22. PubMed ID: 16103773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of Cytomegalovirus Transmission via Breast Milk in Extremely Low Birth Weight Infants.
    Yoo HS; Sung SI; Jung YJ; Lee MS; Han YM; Ahn SY; Chang YS; Park WS
    Yonsei Med J; 2015 Jul; 56(4):998-1006. PubMed ID: 26069123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.